Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 7 | 30 | 330 | 9,860 | 3,610 |
| Cost of Goods | 0 | 0 | 0 | 1,500 | 1,160 |
| Gross Profit | 7 | 30 | 330 | 8,350 | 2,450 |
| Operating Expenses | 10,470 | 9,300 | 12,620 | 12,360 | 11,590 |
| Operating Income | -10,463 | -9,270 | -12,290 | -3,500 | -8,980 |
| Interest Expense | 0 | 30 | 50 | 60 | 100 |
| Other Income | 443 | 940 | 1,330 | -570 | 0 |
| Pre-tax Income | -10,020 | -8,360 | -11,010 | -4,130 | -9,080 |
| Net Income Continuous | -10,024 | -7,940 | -8,800 | -4,138 | -9,087 |
| Net Income | $-10,020 | $-8,360 | $-11,010 | $-4,130 | $-9,080 |
| EPS Basic Total Ops | -146.46 | 151.26 | -211.29 | -88.84 | -194.48 |
| EPS Basic Continuous Ops | -145.28 | -144.63 | -168.91 | -88.04 | -195.00 |
| EPS Diluted Total Ops | -146.46 | 151.26 | -211.29 | -88.84 | -194.48 |
| EPS Diluted Continuous Ops | -145.28 | -144.63 | -168.91 | -88.04 | -195.00 |
| EBITDA(a) | $-10,343 | $-8,700 | $-12,050 | $-3,190 | $-8,680 |